SQZ
Price:
$0.435
Market Cap:
$12.83M
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations wi...[Read more]
Industry
Biotechnology
IPO Date
2020-10-30
Stock Exchange
NYSE
Ticker
SQZ
According to SQZ Biotechnologies Company’s latest financial reports and current stock price. The company's current Enterprise Value is 24.11M. This represents a change of 1.99% compared to the average of 1.15M of the last 4 quarters.
The mean historical Enterprise Value of SQZ Biotechnologies Company over the last ten years is 112.54M. The current 24.11M Enterprise Value has changed 2.04% with respect to the historical average. Over the past ten years (40 quarters), SQZ's Enterprise Value was at its highest in in the September 2021 quarter at 311.79M. The Enterprise Value was at its lowest in in the December 2022 quarter at -14916451.04.
Average
112.54M
Median
131.39M
Minimum
-14916451.04
Maximum
240.48M
Discovering the peaks and valleys of SQZ Biotechnologies Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 418.13%
Maximum Annual Enterprise Value = 240.48M
Minimum Annual Increase = -108.65%
Minimum Annual Enterprise Value = -14916451.04
Year | Enterprise Value | Change |
---|---|---|
2022 | -14916451.04 | -108.65% |
2021 | 172.46M | 418.13% |
2020 | 33.28M | -86.16% |
2019 | 240.48M | 83.03% |
The current Enterprise Value of SQZ Biotechnologies Company (SQZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
63.61M
5-year avg
112.54M
10-year avg
112.54M
SQZ Biotechnologies Company’s Enterprise Value is greater than AN2 Therapeutics, Inc. (3.67M), less than Miromatrix Medical Inc. (90.06M), greater than Inhibikase Therapeutics, Inc. (7.09M), less than PMV Pharmaceuticals, Inc. (40.92M), less than Anebulo Pharmaceuticals, Inc. (41.53M), greater than Comera Life Sciences Holdings, Inc. (-913895.00), greater than SAB Biotherapeutics, Inc. (14.31M), greater than Processa Pharmaceuticals, Inc. (-1283408.00), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), less than Third Harmonic Bio, Inc. (241.43M), greater than Lipella Pharmaceuticals Inc. (3.01M), less than Senti Biosciences, Inc. (33.02M), less than Fennec Pharmaceuticals Inc. (131.47M), greater than Monopar Therapeutics Inc. (2.29M), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Quoin Pharmaceuticals, Ltd. (218.65K), less than Candel Therapeutics, Inc. (194.11M), greater than Werewolf Therapeutics, Inc. (-10348556.00), less than Kezar Life Sciences, Inc. (30.16M), less than Nuvation Bio Inc. (947.94M),
Company | Enterprise Value | Market cap |
---|---|---|
3.67M | $30.44M | |
90.06M | $92.95M | |
7.09M | $10.00M | |
40.92M | $77.28M | |
41.53M | $46.68M | |
-913895.00 | $682.38K | |
14.31M | $26.21M | |
-1283408.00 | $4.17M | |
-6447751.00 | $4.42M | |
241.43M | $493.17M | |
3.01M | $4.10M | |
33.02M | $13.14M | |
131.47M | $144.76M | |
2.29M | $8.41M | |
-5743713.00 | $11.01M | |
-6333315.00 | $8.20M | |
1.48M | $4.17M | |
218.65K | $3.06M | |
194.11M | $197.00M | |
-10348556.00 | $88.28M | |
30.16M | $40.82M | |
947.94M | $692.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SQZ Biotechnologies Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SQZ Biotechnologies Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is SQZ Biotechnologies Company's Enterprise Value?
What is the highest Enterprise Value for SQZ Biotechnologies Company (SQZ)?
What is the 3-year average Enterprise Value for SQZ Biotechnologies Company (SQZ)?
What is the 5-year average Enterprise Value for SQZ Biotechnologies Company (SQZ)?
How does the current Enterprise Value for SQZ Biotechnologies Company (SQZ) compare to its historical average?